Investors.scholarrock.com

  1. Home
  2. Investors.scholarrock.com

Scholar Rock to Advance Antimyostatin Program to Develop Novel

WebCompany plans to expand into cardiometabolic disorders, leveraging its experience in myostatin inhibition; Preclinical data support advancing SRK-439, a novel …

Actived: 5 days ago

URL: https://investors.scholarrock.com/news-releases/news-release-details/scholar-rock-advance-antimyostatin-program-develop-novel

Scholar Rock Announces FDA Clearance of IND Application to …

WebRandomized Phase 2 proof-of-concept trial with apitegromab in patients with obesity on GLP-1 therapies on track to initiate mid-2024 Study aims to show the …

Category:  Health Go Health

Scholar Rock Announces FDA Clearance of IND Application to …

WebScholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity January 23, 2024

Category:  Health Go Health

Scholar Rock Receives Fast Track Designation from the U.S. FDA …

Web- Builds on Priority Medicines (PRIME) designation recently granted by the European Medicines Agency (EMA) recognizing the unmet medical needs of patients …

Category:  Medical,  Medicine Go Health

Scholar Rock Provides Corporate Update and Highlights Priorities …

WebThe Company will provide additional clinical data updates as they become available in 2024. Completed an equity financing of $98 million in October. As of …

Category:  Health Go Health

Scholar Rock and the Miami Project to Cure Paralysis Present

WebPreclinical data demonstrate improvement in muscle pathology and function following experimental spinal cord injury Expands potential opportunities for SRK-015 into a wide …

Category:  Health Go Health

Scholar Rock to Present New Apitegromab Data Including 24 …

Web- 24-month apitegromab data from Phase 2 TOPAZ trial presented by Thomas Crawford, M.D. - Also presenting patient and caregiver observations from real-world …

Category:  Health Go Health

Scholar Rock to Present at the Cowen 43rd Annual Health Care …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 27, 2023-- Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the …

Category:  Health Go Health

Scholar Rock to Advance Antimyostatin Program to Develop …

WebTitle: Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorder s Created Date: 20231011204808Z

Category:  Health Go Health

Scholar Rock Announces Presentation of New Preclinical Data …

WebSRK-439 is a novel selective myostatin inhibitor designed for the treatment of cardiometabolic disorders Preclinical data supports the potential of SRK-439 to preserve …

Category:  Health Go Health

Scholar Rock to Present at Cowen’s 42nd Annual Health Care …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 25, 2022-- Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the …

Category:  Health Go Health

Scholar Rock to Present at Cowen & Company 36th Annual Health …

WebCAMBRIDGE, Mass., March 1, 2016 – Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively target supracellular activation of growth …

Category:  Health Go Health

Scholar Rock to Participate in Upcoming Investor Conferences

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 28, 2024-- Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing …

Category:  Health Go Health

Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next …

WebDr. Backstrom has a unique combination of clinical research and development, regulatory, and leadership experience, which spans 30 years across the …

Category:  Health Go Health

Deep Insights, Impactful Medicines

WebMost frequently reported TEAEs*: headache (38%), pyrexia (38%), COVID-19 (36%), nasopharyngitis (36%), & upper respiratory tract infection (33%) TEAEs were …

Category:  Health Go Health

Scholar Rock Appoints Caryn Parlavecchio as Chief Human …

WebCAMBRIDGE, Mass. -- (BUSINESS WIRE)--Aug. 16, 2021-- Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious …

Category:  Health Go Health

Events & Presentations

WebPast Events. March 20, 2024. BMO Biopharma Spotlight Series: Obesity Day: Scholar Rock. March 12, 2024. 3rd Annual Jefferies Biotech on the Bay Summit. March 5, 2024 9:10 …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Mental health interventions for individuals

 › Alexian brothers mental health

 › Metabolic health blood test app

 › Home health agency duties

 › Bbc good food healthy recipes

 › Usda healthy food program

 › Health and safety officer summary

 › Healthy calorie deficit snacks

 › National department of health icd 10

 › Seaside mental health reviews

Recently Searched

 › Machine learning health monitoring

 › Hca midwest health customer portal

 › Essentia health duluth new hospital

 › Dr clare gosek capital health

 › Portrait health center woodcliff lake nj

 › Positive health and fitness ad

 › Global health equity driven funding

 › Health insurance in hampton nh

 › Healthy home inspection near me

 › Bournemouth university health and social studies